Anavex Life Sciences: Fiscal Q2 Earnings Snapshot
Anavex Life Sciences: Fiscal Q1 Earnings Snapshot
Anavex Life Sciences: Fiscal Q4 Earnings Snapshot
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot
The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.
The company's first-quarter earnings report detailed positive news regarding its pipeline.
A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business.
Short-sellers have piled into this clinical-stage biopharma stock.
The biotech's shares have been steadily leaking higher following positive late-stage Alzheimer's disease trial results.